Cell therapy for neuropathic pain in spinal cord injuries

Bibliography

• MERSKEY H, BOGDUK N: Classification of Chronic Pain: Descriptions of Chronic Syndromes and Definitions of Pain Terms. 2' Ed. Merskey H, Bogduk N (Eds), IASP Press, Seattle, USA (1994).
   Google Scholar
• BOVIVIE J: Central pain. In: Textbook of Pain. Wall PD, Melzack R (Eds), Churchill Livingston, London, UK (1994):871–902.
   Google Scholar
• SIDDALL P, COUSINS MJ: Spine update. Spinal pain mechanisms. Spine (1997) 22:98–104.
   Google Scholar
• YAKSH TL, HUA XY, KALCHEVA I, NOZAKI-TAGUCHI N, MARSALA M: The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc. Natl. Acad. Sci. USA (1999) 96:7680–7686.
   PubMed Web of Science ®Google Scholar
• SIDDALL PJ, YEZIERSKI RP,LOESER JD: Taxonomy and epidemiology of spinal cord pain. In: Spinal Cord Injury Pain: Assessment, Mechanisms, Management.Yezierski RP, Burchiel KJ (Eds), IASP Press, Seattle, USA (2002):9–24.
   Google Scholar
• SIDDALL PJ, TAYLOR DA, MCCLELLAN JM, RUTKOWSKI SB, COUSINS MJ: Pain report and the relationship of pain to physical factors in the first 6 months following spinal cord injury. Pain (1999) 81:187–197.
   PubMed Web of Science ®Google Scholar
• MCLEOD JG: Investigation of peripheral neuropathy. I Nemo]. Neurosurg. Psych. (1995) 363:274–283.
   Google Scholar
• KOLTZENBERG M: Afferent mechanisms mediating pain and hyperalgesia in neuralgia. In: Reflex Sympathetic Dystrophy: A Reappraisal. Janig W, Stanton-Hicks M (Eds), IASP Press, Seattle, USA (1996):123–150.
   Google Scholar
• MACPHERSON RD: New directions inpain management. Drugs Today (2002) 38:135–145.
   PubMed Web of Science ®Google Scholar
• TURK DC, OKIFUJI A: Treatment of chronic pain patients: clinical outcome, cost effectiveness, and cost benefits. Grit. Rev Phys. Med. Rehabil. Med. (1998) 10:181–208.
   Google Scholar
• BREIVIK H: Opioids in cancer and chronicnoncancer pain therapy: indications and controversies. Acta Anesthesia Scand. (2001) 45:1059–1066.
   PubMed Web of Science ®Google Scholar
• FINNERUP NB, JOHANNESEN IL, SINDRUP SH, BACH FW, JENSEN TS: Pharmacological treatment of spinal cord injury pain. In: Spinal Cord Injury Pain: Assessment, Mechanisms, Management.Yezierski RP, Burchiel KJ (Eds), IASP Press, Seattle, USA (2002):341–351.
   Google Scholar
• SIDDALL PJ, YEZIERSKI RP, LOESER J: Pain following spinal cord injury: clinical features, prevalence, and taxonomy. IASP Newsletter (2000) 3:3–7.
   Google Scholar
• LATCHMAN DS: Gene therapy with herpes simplex virus vectors: progress and prospects for clinical neuroscience. Neuroscientist (2001) 7:528–537.
   PubMed Web of Science ®Google Scholar
• YAKSH TL: Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci. USA (1999) 20:329–337.
   PubMed Web of Science ®Google Scholar
• WILSON S, CHANG K, VIVEROS 0: Opioid peptide synthesis in bovine and human adrenal chromaffin cells. Peptides (1981) 2(Suppl.):83–88.
   Google Scholar
• HAMA AT, SAGEN J: Reduced pain-relatedbehavior by adrenal medullary transplants in rats with experimental painful peripheral neuropathy. Pain (1994) 52:223–231.
   Web of Science ®Google Scholar
• SIEGAN JB, SAGEN J: Attenuation of formalin pain responses in the rat by adrenal medullary transplants in the spinal subarachnoid space. Pain (1997) 70:279–285.
   PubMed Web of Science ®Google Scholar
• SAGEN J, KEMMLER JE: Increased levels of met-enkephalin like-immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplants. Brain Res. (1989) 502:1–10.
   PubMed Web of Science ®Google Scholar
• SAGEN J, KEMMLER JE, WANG H: Adrenal medullary transplants increase spinal cord cerebral spinal fluid catecholamine levels and reduce pain sensitivity. Neurochem. (1991) 56:623–627.
   PubMed Web of Science ®Google Scholar
• WANG H, SAGEN J: Absence of appreciable tolerance and morphine cross-tolerance in rats with adrenal medullary transplants in the spinal cord. Neuropharm. (1994) 33:681–692.
   PubMed Web of Science ®Google Scholar
• HAMA AT, SAGEN J: Induction of spinal NADPH-diaphorase by nerve injury is attenuated by adrenal medullary transplants. Brain Res. (1994) 640:345–351.
   PubMed Web of Science ®Google Scholar
• SIEGAN JB, HAMMA AT, SAGEN J: Alterations in rat spinal cord cGMP by peripheral nerve injury and adrenal medullary transplantation. Neurosci. Lett. (1996) 215:49–52.
   PubMed Web of Science ®Google Scholar
• SAGEN J, WANG H: Adrenal medullary grafts suppress c-fos induction in spinal neurons of arthritic rats. Neurosci. Lett. (1995) 192:181–184.
   PubMed Web of Science ®Google Scholar
• SIEGAN JB, SAGEN J: Attenuation of NMDA-induced spinal hypersensitivity by adrenal medullary transplants. Brain Res. (1995) 680:88–98.
   PubMed Web of Science ®Google Scholar
• IBUKI T, HAMA AT, WANG XT, PAPPAS GD, SAGEN J: Loss of GABAimmunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neurosci. (1997) 76:845–858.
   PubMed Web of Science ®Google Scholar
• SIEGAN JB, HERZBERG U,FRYDEL BR, SAGEN J: Adrenal medullary transplants reduce formalin-evoked c-fos expression in the rat spinal cord. Brain Res. (2002) 944:174–183.
   PubMed Web of Science ®Google Scholar
• HENTALL ID, NOGA BR, SAGEN J: Spinal allografts of adrenal medulla block nociceptive facilitation in the dorsal horn. Neurophysiol (2001) 85:1788–1792.
   PubMed Web of Science ®Google Scholar
• SAGEN J, WANG H, TRESCO PA, AEBISCHER P: Transplants of immunologically isolated xenogenic chromaffin cells provide a long-term source of pain-reducing neuroactive substances.Neurosci. (1993) 13:2415–2423.
   PubMed Web of Science ®Google Scholar
• BUCHSER E, GODDARD M, HEYD B et al.: Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience. Anesthesiology (1996) 85:1005–1012.
   Google Scholar
• BREWER KL, YEZIERSKI RP: Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury. Brain Res. (1998) 798:83–92.
   PubMed Web of Science ®Google Scholar
• YU W, HAO XJ, XU XJ et al.: Long-termalleviation of allodynia-like behaviors by intrathecal implantation of bovine chromaffin cells in rats with spinal cord injury. Pain (1998) 74:115–122.
   PubMed Web of Science ®Google Scholar
• HAINS BC, CHASTAIN KM, EVERHART AW, MCADOO DJ, HULSEBOSCH CE: Transplants of adrenal medullary chromaffin cells reduce forelimb and hindlimb allodynia in a rodent model of chronic central pain after spinal hemisection injury. Exp. Neurol (2000) 164:426–437.
   PubMed Web of Science ®Google Scholar
• YU W, HAO JX, XU XJ et aL: Immunoisolating encapsulation of intrathecally implanted bovine chromaffin cells prolongs their survival and produces anti-allodynic effect in spinally injured rats. Eur. J. Pain (1998) 2:143–151.
   PubMed Web of Science ®Google Scholar
• PAPPAS GD, LAZORTHES Y, BES JC, TAFANI M, WINNIE AP: Relief of intractable cancer pain by human chromaffin cell transplants: experience at two medical centers. Neurol Res. (1997) 19:71–77.
   PubMed Web of Science ®Google Scholar
• PAICE JA: Mechanisms and managementof neuropathic pain in cancer. J. Support Oncol (2003) 1:107–120.
   PubMedGoogle Scholar
• TKACZUK J, BES JC, DUPLAN H et al.: Intrathecal grafting of unencapsulated adrenal medullary tissue can bring CD4 T lymphocytes into CSF: a potentially deleterious event for the graft.Cell Transplant. (2000) 9:79–91.
   PubMed Web of Science ®Google Scholar
• BHATTACHARYA N, CHHETRI MK, MUKHERJEE KL et al.: Human fetal adrenal transplant: a possible role in relieving intracftable pain in advanced rheumatoid arthritis. Clin. Exp. Obstet. Cynecol (2002) 29:197–206.
   PubMedGoogle Scholar
• BES JC, FRYDEL BR, POTTER ED et al: Human embryonic and fetal adrenal glands as sources of neural precursors for possible transplantation strategies. Am. Soc. Neurol Transplant. Repair (2001) 8:61.
   Google Scholar
• GREENE LA, TISCHLER AS:Establishment of a noradrenergic clonal cell line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA (1976) 73:2424–2428.
   PubMed Web of Science ®Google Scholar
• BYRD JC, HADJICONSTANTINOU M, CAVALLA D: Epinephrine synthesis in the PC12 pheochromocytoma cell line. Eur. Pbaramacol (1986) 127:139–142.
   PubMed Web of Science ®Google Scholar
• YOSHIKAWA M, NAKAYAMA H, UENO S et al: Chronic fentanyl treatments induce the up-regulation of mu opioid receptor mRNA in rat pheochromocytoma cells. Bran) Res. (2000) 859:217–223.
   PubMed Web of Science ®Google Scholar
• STOCKLEY TL, CHANG PL: Non-autologous transplantation with immuno-isolation in large animals-a review. Ann. NY Acad. Sci. (1997) 831:408–426.
   PubMed Web of Science ®Google Scholar
• WU HH, LESTER BR, SUN Z,WILCOX GL: Antinociception following implantation of mouse B16 melanoma cells in mouse and rat spinal cord. Pain (1994) 56:203–210.
   PubMed Web of Science ®Google Scholar
• DE LA CALLE JL, MENA MA, GONZALEZ-ESCALADA JR, PAINO CL: Intrathecal transplantation of neuroblastoma cells decreases heat hyperalgesia and cold allodynia in a rat model of neuropathic pain. Bran) Res. Bull. (2002) 59:205–211.
   PubMed Web of Science ®Google Scholar
• WU HH, WILCOX GL, MCLOON SC: Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance. " Neurosci. (1994) 14:4806–4814.
   PubMed Web of Science ®Google Scholar
• SAITOH Y, TAKI T, ARITA N, OHNISHI T, HAYAKAWA T: Analgesia induced by transplantation of encapsulatedtumor cells secreting beta-endorphin. Neurosurg. (1995) 82:630–634.
   Web of Science ®Google Scholar
• ISHII K, ISONO M, INOUE R, HORI S: Attempted gene therapy for intractable cancer pain: dexamethasone-mediated exogenous control of beta-endorphin secretion in genetically modified cells and intrathecal transplantation. Exp. Neurol (2000) 166:90–98.
   PubMed Web of Science ®Google Scholar
• LENDAHL U, MCKAY RD: The use of cell lines in neurobiology. Trends Neurosci. (1990) 13:132–137.
   PubMed Web of Science ®Google Scholar
• JAT PS, SHARP PA: Cell lines established by a temperature-sensitive simian virus 40 large T antigen gene are growth restricted at nonpermissive temperature. Ma Cell. Biol. (1989) 9:1672–1681.
   Web of Science ®Google Scholar
• JAT PS, NOBLE MD, ATALIOTIS Petal.: Direct derivation of conditionally immortal cell lines from an H-21c." -tsA58 transgenic mouse. Proc. Natl. Acad. Sci. USA (1991) 88:5096–5100.
   Google Scholar
• JIANG JY, LYETH BG, CLIFTON GL et al.: Relationship between body and brain temperature in traumatically brain-injured rodents.' Neurosurg. (1991) 74:492–496.
   Web of Science ®Google Scholar
• WHITE LA, EATON MJ, CASTRO MC et al.: Distinct regulatory pathways control neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons." Neurosci. (1994) 14:6744–6753.
   Google Scholar
• WHITTEMORE SR, WHITE LA: Target regulation of neuronal differentiation in a temperature-sensitive cell line derived from medullary raphe. Brain Res. (1993) 615:27–40.
   PubMed Web of Science ®Google Scholar
• EATON MJ, WHITTEMORE SR: Autocrine BDNF secretion enhances the survival and serotonergic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS. Exp. Neurol (1996) 140:105–114.
   PubMed Web of Science ®Google Scholar
• EATON MJ, DANCAUSSE HR, SANTIAGO DI, WHITTEMORE SR: Lumbar transplants of immortalized serotonergic neurons alleviates chronic neuropathic pain. Pain (1997) 72:59–69.
   PubMed Web of Science ®Google Scholar
• EATON MJ, KARMALLY S,MARTINEZ MA et al: Lumbar transplants of neurons genetically modified to secrete galanin reverse pain-like behaviors after partial sciatic nerve injury. J. Peripbec Nerv. Syst. (1999) 4:245–257.
   PubMed Web of Science ®Google Scholar
• CEJAS PJ, MARTINEZ M, KARMALLY Set al.: Lumbar transplant of neurons genetically modified to secrete brain-derived 1867neurotrophic factor attenuate allodynia and hyperalgesia after sciatic nerve constriction. Pahl (2000) 86:195–210.
   Google Scholar
• EATON MJ, PLUNKETT JA, MARTINEZ MA et al.: Transplants of neuronal cells bio-engineered to synthesize GABA alleviate chronic neuropathic pain. Cell Transplant. (1999) 8:87–101.
   PubMed Web of Science ®Google Scholar
• HAINS BC, JOHNSON KM, MCADOO DJ, EATON MJ, HULSEBOSCH CE: Engraftment of immortalized serotonergic neurons enhances locomotor function and attenuates pain-like behavior following spinal hemisection injury in the rat. Exp. Neurol. (2001) 171:361–378.
   PubMed Web of Science ®Google Scholar
• HAINS BC, EVERHART AW, FULLWOOD SD, HULSEBOSCH CE: Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat. Exp. Neurol. (2002) 175:347–362.
   PubMed Web of Science ®Google Scholar
• HAINS BC, YUCRA JA, EATON MJ, HULSEBOSCH CE: Intralesion transplantation of serotonergic precursors enhances locomoter recovery but has no effect on development of chronic central pain following hemisection injury in rats. Neurosci. Lett. (2002) 324:222–226.
   PubMed Web of Science ®Google Scholar
• HAINS BC, FULLWOOD SD,EATON MJ, HULSEBOSCH CE: Subdural engraftment of serotonergic neurons following spinal hemisection restores spinal serotonin, downregulates the serotonin transporter, and increases BDNF tissue content in the rat. Brain Res. (2001) 913:35–46.
   PubMed Web of Science ®Google Scholar
• HAINS BC, JOHNSON KM,EATON MJ, WILLIS WD,HULSEBOSCH CE: Serotonergic neural precursor cell grafts attenuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat. Neurosci (2003) 116:1097–1110.
   PubMed Web of Science ®Google Scholar
• HAINS BC, WILLIS WD,HULSEBOSCH CE: Serotonin receptors 5-HT 1 A and 5-HT3 reduce hyperexcitability of dorsal horn neurons after chronic spinal cord hemisection injury in rat. Exp. Brain Res. (2003) 149:174–186.
   PubMed Web of Science ®Google Scholar
• EATON MJ, FRYDEL B, LOPEZ T et al.: Generation and initial characterization of conditionally immortalized chromaffincells.Biochem. (2000) 79:38–57.
   Web of Science ®Google Scholar
• UNSICKER K: The chromaffin cell: paradigm in cell, developmental and growth factor biology.' Anat. (1993) 183:207–221.
   PubMed Web of Science ®Google Scholar
• LIVETT M, SPECTOR S,SJOERDSMA A, UDENFRIEND S: Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. j. Pharmacol. Exp. Thec (1965) 148:1–8.
   PubMed Web of Science ®Google Scholar
• PICKEL V, JOH T, FIELD P, BECKER C, REIS D: Cellular localization of tyrosine hydroxylase by immunohistochemistry. Histochem. Cytochem. (1975) 23:1–12.
   PubMed Web of Science ®Google Scholar
• TOTZAUER I, AMSELGRUBER W, SINOWATZ F, GRATZL M: Early expression of chromogranin A and tyrosine hydroxylase during prenatal development of the bovine adrenal gland. Anat. Embryo]. (Berl) (1995) 191:139–143.
   PubMedGoogle Scholar
• CZECH KA, POLLAK R, PAPPAS GD, SAGEN J: Bovine chromaffin cells for CNS transplantation do not elicit xenogenic T cell proliferative responses M vitro. Cell Transplant. (1996) 5:257–267.
   PubMed Web of Science ®Google Scholar
• EATON MJ, MARTINEZ M, FRYDEL B et al.: Initial characterization of the transplant of immortalized chromaffin cells for the attenuation of chronic neuropathic pain. Cell Transplant. (2000) 9:637–656.
   PubMed Web of Science ®Google Scholar
• SAUER B, HENDERSON N: Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage Pl. Proc. Nati Acad. Sci. USA (1988) 85:5166–5170.
   PubMed Web of Science ®Google Scholar
• SAUER B: Inducible gene targeting in miceusing the cre/lox system. Methods (1998) 14:381–392.
   PubMed Web of Science ®Google Scholar
• PAILLARD F: Reversible cellimmortalization with the cre-lox system. Hum. Gene Ther. (1999) 10:1597–1598.
   PubMed Web of Science ®Google Scholar
• EATON MJ, HERMAN JP, JULLIEN N et al.: Immortalized chromaffin cells disimmortalized with Cre/lox site-directed recombination for use in cell therapy for pain. Exp. Neurol. (2002) 175:49–60.
   PubMed Web of Science ®Google Scholar
• WESTERMAN KA, LEBOULCH P: Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc. Nati Acad. Sci. USA (1996) 93:8971–8976.
   PubMed Web of Science ®Google Scholar
• KELLENDONK C, TRONCHE F, MONAGHAN AP et al.: Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res. (1996) 24:1404–1411.
   PubMed Web of Science ®Google Scholar
• KELLENDONK C, TRONCHE F, CASANOVA E et al.: Inducible site-specific recombination in the brain. J. Ma Biol. (1999) 285:175–182.
   Web of Science ®Google Scholar
• ALESSANDRI G, EMANUELI C, MADEDDU P: Genetically engineered stem cell therapy for tissue regeneration. Ann. NY Acad. Sci. (2004) 1015:271–284.
   PubMed Web of Science ®Google Scholar
• HENON PR: Human embryonic or adult stem cells: an overview on ethics and perspectives for tissue engineering.Adv. Exp. Med. Biol. (2003) 534:27–45.
   PubMed Web of Science ®Google Scholar
• VESCOVI AL, SNYDER EY:Establishment and properties of neural stem cell clones: plasticity in vitro and in vivo. Thalia Pathol. (1999) 9:569–598.
   Web of Science ®Google Scholar
• BES JC, SAGEN J: Dissociated human embryonic and fetal adrenal glands in neural stem cell culture system: open fate for neuronal, nonneuronal, and chromaffin lineages? The Chomaffin Cell, Transmitter Biosynthesis, Storage, Release, Actions, and Informatics, 11th International Symposium on Chromaffin Cell Biology. Ann. NY Acad. Sci. (2002) 971:563–572.
   PubMed Web of Science ®Google Scholar
• LIN CR, WU PG, SHIH HC et al.: Intrathecal spinal progenitor cell transplantation for the treatment of neuropathic pain. Cell Transplant. (2002) 11:17–24.
   PubMed Web of Science ®Google Scholar
• ORTEGA JD, SAGEN J, PAPPAS GD: Survival and integration of bovine chromaffin cells transplanted into rat central nervous system with exogenous trophic factors. Comp. Neurol. (1992) 323:13–24.
   PubMed Web of Science ®Google Scholar
• HANSEN JT, NOTTER MFD, OKAWARA SH, GASH DM: Organization, fine structure, and viability of the human adrenal medulla: considerations for neural transplantation. Ann. Neurol. (1988) 24:599–609.
   PubMed Web of Science ®Google Scholar
• SOL JC, SALLERIN B, LARRUE S et al.:Intrathecal xenogeneic chromaffin cell grafts reduce nociceptive behaviour in a rodent tonic pain model. Exp. Neurol. (2004) 186:198–211.
   PubMed Web of Science ®Google Scholar
• SAGEN J, PAPPAS GD, PERLOW MJ: Alterations in nociception following adrenal medullary transplants into the periaqueductal gray. Exp. Thalia Res. (1987) 67:373–379.
   PubMed Web of Science ®Google Scholar
• TKACZUK J, BES JC, DEBOUET DU PORTAL H et al.: Intrathecal allograft of chromaffin cells for intractable pain treatment: a model for understanding CNS tolerance mechanisms in humans. Transplant. Proc. (1997) 29:2356–2357.
   Google Scholar
• JOSEPH JM, GODDARD MB, MILLS J et al.: Transplantation of encapsulated bovine chromaffin cells in the sheep 1868subarachnoid space: a preclinical study for the treatment of cancer pain.Cell Transplant. (1994) 3:355–364.
   PubMed Web of Science ®Google Scholar
• WANG H, SAGEN J: Attenuation of pain-related hyperventilation in adjuvant arthritic rats with adrenal medullary transplants in the spinal subarachnoid space. Pain (1995) 63:313–320.
   PubMed Web of Science ®Google Scholar
• SAGEN J, WANG H: Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplants. Eur. Pharmacol (1990) 179:427–433.
   PubMed Web of Science ®Google Scholar
• WHITE LA, WHITTEMORE SR: Immortalization of raphe neurons: an approach to neuronal function in vitro and in vivo. j Chem. Neuroanat. (1992) 5:327–330.
   PubMed Web of Science ®Google Scholar
• WHITTEMORE SR, WHITE LA, SHIHABUDDIN LS, EATON MJ: Phenotypic diversity in neuronal cell lines derived from raphe nucleus by retroviral transduction. Methods (1995) 7:285–296.
   Google Scholar
• DUPLAN H, LI RY, VUE C et al.: Grafts of immortalized chromaffin cells bio-engineered to improve Met-enkephalin release also reduce formalin-evoked c-fos expression in rat spinal cord. Neurosci. Lett. (2004) 370:1–6.
   PubMed Web of Science ®Google Scholar
• DUPLAN H, LI RY, VUE C et al: Anti-nociceptive effect of a conditionally immortalized chromaffin cell line genetically modified to express met-enkephalin in a rodent tonic pain model. Acta Neurochir (2002) 144:1106.
   Google Scholar